News Biomaterials & Biomolecular Systems

  • A nanorobot (orange) in Prof. Berna Özkale Edelmann's laboratory. The scientist wants to use such tiny robots and so-called smart microgels to influence the development of stem cells. This and eight other research projects will be funded with ERC Starting Grants. Image: Astrid Eckert / TUM

    EU funding for projects on medicine, space exploration, software, and biomaterials

    Nine ERC Starting Grants awarded to TUM researchers

    05 September 2024 | ERC Starting Grant for MIBE-PI Prof. Özkale Edelmann:  Her goal ist to goal is to turn stem cells into heart cells and thus help people suffering from the consequences of a heart attack.

  • Oliver Lieleg, Professor of Biopolymer Materials at TUM, and his team develop mucin-based materials for medical applications.

    Multi-purpose mucus

    What mucins can do in medicine

    27 May 2024 | Oliver Lieleg, Professor of Biopolymer Materials at TUM, and his team develop mucin-based materials for medical applications such as coatings for contact lenses and intubation tubes.

  • A team of researchers has made a significant advance in prime editing, the most versatile gene editing technology to date. They have developed a method for the targeted degradation of old DNA segments to make room for the insertion of new sequences. The illustration shows two hands and a drawn DNA double helix. One hand is erasing an old sequence, the other one is drawing the new one.

    New method makes space for DNA insertions

    Expanding the gene editing toolbox

    01 February 2024 | Researchers have made a significant advance in prime editing, the most versatile gene editing technology to date. They have developed a method for the targeted degradation of old DNA segments to make room for the insertion of new sequences.

  • Dr. Klaus Wagenbauer

    Magazine "Capital" awards talents from business, politics and society

    Klaus Wagenbauer among the "Top 40 under 40"

    24 November 2023 | Dr. Klaus Wagenbauer is among this year's „Top 40 under 40“ of the magazine „Capital“. The physicist has been working on further developing DNA nanotechnology since his doctorate at TUM. 2022, he founded the Spin-off Plectonic Biotech together with other TUM researchers.

  • DNA nanoturbine

    Tiny turbines for nanorobotics

    Nanoturbine made from DNA material

    26 October 2023 | Using DNA origami technology, an international research team has developed a tiny turbine for nanorobotics.

  • Virus trap

    MIBE in the media | Breaking Lab video with Hendrik Dietz, Professor of Biomolecular Nanotechnology

    Video: DNA nanotechnology in medical applications

    18 October 2023 | Breakling Lab video on DNA origami technology: Nanoswitches for tumor targeting, virus traps, and new possibilites in molecular diagnostics

  • Doctoral candidate Phlipp Harder produces thousands of new microrobots in the lab. Image: Astrid Eckert / TUM

    Opportunities for cancer treatment and wound healing

    Microrobots for the study of cells

    06 September 2023 | Researchers at TUM have developed the world’s first microrobot (“microbot”) capable of navigating within groups of cells and stimulating individual cells. This might create new possibilities for wound healing and cancer treatment.

  • Artistic illustration: Programmable T-cell engager (PTE) created with DNA origami technology. The PTE is already attached to a tumor cell and recruits a T-cell. Image: Priyanka Oberoi

    DNA origami structures fitted with antibodies help immune system to target cancer cells

    Immunotherapy: Antibody kit to fight tumors

    17 August 2023 | A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells.

  • Gil Westmeyer, Professor of Neurobiological Engineering. Image: Andreas Heddergott / TUM

    New biological tool for tracking cellular processes

    Molecular monitoring of RNA regulation

    14 November 2022 | New biological tool for tracking cellular processes

  • Prof. Gil Westmeyer (l.) and his research team, in collaboration with Kilian Vogele (r.) and the start-up Invitris, have developed a new controlled production method to create bacteriophages for therapeutic use. Image: A. Heddergott / TUM

    Cell-free production of bacteriophages

    Viruses help combat antibiotic-resistant bacteria

    27 July 2022 | A Munich research team has developed a new way to produce bacteriophages efficiently and without risk.

page 1 of 3


Back to the research area Biomaterials & Biomolecular Systems